FindTrial
Sign In

Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00370721
Enrollment
Unknown
Registered
2006-09-01
Start date
2006-03-31
Completion date
Unknown
Last updated
2008-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy

Keywords

Proliferative diabetic retinopathy(PDR), Pan retinal photocoagulation (PRP), Vitreous hemorrhage, Traction retinal detachment, Neovascularization on disc (NVD), Neovascularization elsewhere (NVE), Fibrous proliferation on disc (FPD), Fibrous proliferaiton elsewhere (FPE)

Brief summary

To evaluate the effect of intravitreal bevacizumab on the course of diabetic retinopathy in cases with the signs of active progressive PDR

Interventions

DRUGbevacizumab

Sponsors

Shahid Beheshti University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Cases of active progressive PDR with history of scatter laser photocoagulation

Exclusion criteria

* history of vitrectomy

Design outcomes

Primary

MeasureTime frame
Regression of diabetic retinopathy—
visual acuity—

Secondary

MeasureTime frame
traction retinal detachment—
neovascularization—
pan retinal photocoagulation—
vitreous hemorrhage—
fibrous proliferation—

Countries

Iran

Contacts

Primary ContactHamid Ahmadieh, MD
hahmadieh@hotmail.com+98 21 22585952

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026